Therapeutic Monitoring of Vancomycin Implemented by Eremomycin ELISA
Background/Objectives: Due to a narrow therapeutic window, side-effects, toxicities, and individual pharmacokinetics (PK) variability, WHO classifies vancomycin (VCM) as a “watch antibiotic” whose use should be monitored to improve clinical effectiveness. Availability and ease of use have made the i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/13/12/1133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|